These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2891292)

  • 1. Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertension.
    Dzau VJ; Gibbons GH
    Am J Cardiol; 1987 Dec; 60(17):99I-103I. PubMed ID: 2891292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell biology of vascular hypertrophy in systemic hypertension.
    Dzau VJ; Gibbons GH
    Am J Cardiol; 1988 Oct; 62(11):30G-35G. PubMed ID: 3051993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
    Weir MR; Dzau VJ
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes.
    Dzau VJ
    Curr Opin Nephrol Hypertens; 1993 Jan; 2(1):27-32. PubMed ID: 7922163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition and vascular structure in hypertension.
    Gibbons GH
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S19-24. PubMed ID: 1725196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanical influences on vascular smooth muscle cell function.
    Williams B
    J Hypertens; 1998 Dec; 16(12 Pt 2):1921-9. PubMed ID: 9886878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular angiotensin II as a regulator of muscle tone in vascular resistance vessels. Pathophysiological implications.
    De Mello WC
    Peptides; 2016 Apr; 78():87-90. PubMed ID: 26944358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of peptide vasoconstrictors on vessel structure.
    Hahn AW; Resink TJ; Mackie E; Scott-Burden T; Bühler FR
    Am J Med; 1993 Apr; 94(4A):13S-19S. PubMed ID: 8488851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function.
    Dzau VJ
    J Cardiovasc Pharmacol; 1984; 6 Suppl 2():S377-82. PubMed ID: 6206346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New aspects of the pathophysiology and pathogenesis of arterial hypertension--a review of the literature].
    Franz C; Linss G; Franz N
    Z Gesamte Inn Med; 1990 Dec; 45(24):723-8. PubMed ID: 2151671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in hypertension: mechanisms and therapeutic targets.
    Bátkai S; Thum T
    Curr Hypertens Rep; 2012 Feb; 14(1):79-87. PubMed ID: 22052337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endothelium and control of blood vessel function in health and disease.
    Schiffrin EL
    Clin Invest Med; 1994 Dec; 17(6):602-20. PubMed ID: 7895424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms of vascular hypertrophy in hypertension].
    Tedgui A
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():67-72. PubMed ID: 8215782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factors and vascular wall.
    Chabrier PE
    Int Angiol; 1996 Jun; 15(2):100-3. PubMed ID: 8803632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth or antigrowth: angiotensin and the endothelium.
    Stoll M; Meffert S; Stroth U; Unger T
    J Hypertens; 1995 Dec; 13(12 Pt 2):1529-34. PubMed ID: 8903605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular remodeling in hypertension: role of autocrine-paracrine factors.
    Gibbons GH
    Blood Press Suppl; 1995; 2():49-54. PubMed ID: 7582074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme in cardiovascular and adrenal tissues and implications for successful blood pressure management.
    Melby JC
    Am J Cardiol; 1992 Apr; 69(10):2C-7C. PubMed ID: 1546636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets, growth factors, and vascular smooth-muscle cells in hypertension and diabetes.
    Mikhail N; Fukuda N; Tremblay J; Hamet P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S64-74. PubMed ID: 7508064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging in blood vessels. Medicinal agents FOR systemic arterial hypertension in the elderly.
    Rubio-Ruiz ME; Pérez-Torres I; Soto ME; Pastelín G; Guarner-Lans V
    Ageing Res Rev; 2014 Nov; 18():132-47. PubMed ID: 25311590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of vascular remodeling in hypertension: role of autocrine-paracrine vasoactive factors.
    Gibbons GH
    Curr Opin Nephrol Hypertens; 1995 Mar; 4(2):189-96. PubMed ID: 7541288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.